The global market for Inactivated Porcine Atrophic Rhinitis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Inactivated Porcine Atrophic Rhinitis Vaccine in Sows is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology, Tianjin Ringpu Bio-Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine.

The Inactivated Porcine Atrophic Rhinitis Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Porcine Atrophic Rhinitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inactivated Porcine Atrophic Rhinitis Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inactivated Porcine Atrophic Rhinitis Vaccine Market Report

Report Metric	Details
Report Name	Inactivated Porcine Atrophic Rhinitis Vaccine Market
Segment by Type	Tissue Culture Origin Cell Line Origin
Segment by Application	Sows Gilts
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology, Tianjin Ringpu Bio-Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Inactivated Porcine Atrophic Rhinitis Vaccine Market report?

Ans: The main players in the Inactivated Porcine Atrophic Rhinitis Vaccine Market are Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology, Tianjin Ringpu Bio-Technology

What are the Application segmentation covered in the Inactivated Porcine Atrophic Rhinitis Vaccine Market report?

Ans: The Applications covered in the Inactivated Porcine Atrophic Rhinitis Vaccine Market report are Sows, Gilts

What are the Type segmentation covered in the Inactivated Porcine Atrophic Rhinitis Vaccine Market report?

Ans: The Types covered in the Inactivated Porcine Atrophic Rhinitis Vaccine Market report are Tissue Culture Origin, Cell Line Origin

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tissue Culture Origin

1.2.3 Cell Line Origin

1.3 Market by Application

1.3.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Sows

1.3.3 Gilts

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Perspective (2020-2031)

2.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Growth Trends by Region

2.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Region (2020-2025)

2.2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031)

2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Dynamics

2.3.1 Inactivated Porcine Atrophic Rhinitis Vaccine Industry Trends

2.3.2 Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers

2.3.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges

2.3.4 Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue

3.1.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue (2020-2025)

3.1.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Players (2020-2025)

3.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue

3.4 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio

3.4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024

3.5 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine Head office and Area Served

3.6 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application

3.7 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Type

4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Type (2020-2025)

4.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031)

5 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Application

5.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Application (2020-2025)

5.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)

6.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)

6.4 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)

7.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)

7.4 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)

8.2 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025)

8.4 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)

9.2 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)

9.4 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)

10.2 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)

10.4 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck Animal Health

11.1.1 Merck Animal Health Company Details

11.1.2 Merck Animal Health Business Overview

11.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.1.4 Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.1.5 Merck Animal Health Recent Development

11.2 HIPRA

11.2.1 HIPRA Company Details

11.2.2 HIPRA Business Overview

11.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.2.4 HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.2.5 HIPRA Recent Development

11.3 Bioveta

11.3.1 Bioveta Company Details

11.3.2 Bioveta Business Overview

11.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.3.4 Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.3.5 Bioveta Recent Development

11.4 China Animal Husbandy Industry

11.4.1 China Animal Husbandy Industry Company Details

11.4.2 China Animal Husbandy Industry Business Overview

11.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.4.4 China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.4.5 China Animal Husbandy Industry Recent Development

11.5 Wuhan Keqian Biology

11.5.1 Wuhan Keqian Biology Company Details

11.5.2 Wuhan Keqian Biology Business Overview

11.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.5.4 Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.5.5 Wuhan Keqian Biology Recent Development

11.6 Pulike Bio-Engineering

11.6.1 Pulike Bio-Engineering Company Details

11.6.2 Pulike Bio-Engineering Business Overview

11.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.6.4 Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.6.5 Pulike Bio-Engineering Recent Development

11.7 Tiankang Animal Science Bio-Technology

11.7.1 Tiankang Animal Science Bio-Technology Company Details

11.7.2 Tiankang Animal Science Bio-Technology Business Overview

11.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.7.4 Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.7.5 Tiankang Animal Science Bio-Technology Recent Development

11.8 Tianjin Ringpu Bio-Technology

11.8.1 Tianjin Ringpu Bio-Technology Company Details

11.8.2 Tianjin Ringpu Bio-Technology Business Overview

11.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction

11.8.4 Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

11.8.5 Tianjin Ringpu Bio-Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck Animal Health

Hipra

Bioveta

China Animal Husbandy Industry

Wuhan Keqian Biology

Tianjin Ringpu Bio-Technology

Pulike Bio-Engineering

Tiankang Animal Science Bio-Technology

List of Tables

Table 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tissue Culture Origin

Table 3. Key Players of Cell Line Origin

Table 4. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2025)

Table 8. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2026-2031)

Table 10. Inactivated Porcine Atrophic Rhinitis Vaccine Market Trends

Table 11. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers

Table 12. Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges

Table 13. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints

Table 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players (2020-2025)

Table 16. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)

Table 17. Ranking of Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Headquarters and Area Served

Table 20. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application

Table 21. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2020-2025)

Table 25. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2026-2031)

Table 27. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2020-2025)

Table 29. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2026-2031)

Table 31. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Animal Health Company Details

Table 47. Merck Animal Health Business Overview

Table 48. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 49. Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 50. Merck Animal Health Recent Development

Table 51. HIPRA Company Details

Table 52. HIPRA Business Overview

Table 53. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 54. HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 55. HIPRA Recent Development

Table 56. Bioveta Company Details

Table 57. Bioveta Business Overview

Table 58. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 59. Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 60. Bioveta Recent Development

Table 61. China Animal Husbandy Industry Company Details

Table 62. China Animal Husbandy Industry Business Overview

Table 63. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 64. China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 65. China Animal Husbandy Industry Recent Development

Table 66. Wuhan Keqian Biology Company Details

Table 67. Wuhan Keqian Biology Business Overview

Table 68. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 69. Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 70. Wuhan Keqian Biology Recent Development

Table 71. Pulike Bio-Engineering Company Details

Table 72. Pulike Bio-Engineering Business Overview

Table 73. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 74. Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 75. Pulike Bio-Engineering Recent Development

Table 76. Tiankang Animal Science Bio-Technology Company Details

Table 77. Tiankang Animal Science Bio-Technology Business Overview

Table 78. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 79. Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 80. Tiankang Animal Science Bio-Technology Recent Development

Table 81. Tianjin Ringpu Bio-Technology Company Details

Table 82. Tianjin Ringpu Bio-Technology Business Overview

Table 83. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product

Table 84. Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)

Table 85. Tianjin Ringpu Bio-Technology Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Inactivated Porcine Atrophic Rhinitis Vaccine Picture

Figure 2. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Tissue Culture Origin Features

Figure 5. Cell Line Origin Features

Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application: 2024 VS 2031

Figure 8. Sows Case Studies

Figure 9. Gilts Case Studies

Figure 10. Inactivated Porcine Atrophic Rhinitis Vaccine Report Years Considered

Figure 11. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region: 2024 VS 2031

Figure 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players in 2024

Figure 15. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024

Figure 17. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)

Figure 19. United States Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)

Figure 23. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2031)

Figure 31. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)

Figure 39. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)

Figure 43. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Merck Animal Health Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 47. HIPRA Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 48. Bioveta Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 49. China Animal Husbandy Industry Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 50. Wuhan Keqian Biology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 51. Pulike Bio-Engineering Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 52. Tiankang Animal Science Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 53. Tianjin Ringpu Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions